|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0008838,
umls-concept:C0013216,
umls-concept:C0017189,
umls-concept:C0040808,
umls-concept:C0045093,
umls-concept:C0205179,
umls-concept:C0332174,
umls-concept:C0337810,
umls-concept:C0346647,
umls-concept:C0684224,
umls-concept:C1257890,
umls-concept:C1516213,
umls-concept:C2603343
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-2-3
|
|
pubmed:abstractText |
This phase II study was initiated to determine the activity and toxicity of a combination of gemcitabine (GEM) and cisplatin (CDDP) in patients with pancreatic cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:Bari?LL,
pubmed-author:BerettaG DGD,
pubmed-author:CascinuSS,
pubmed-author:CatalanoGG,
pubmed-author:CatalanoVV,
pubmed-author:FerrelWW,
pubmed-author:FoaPP,
pubmed-author:FrontiniLL,
pubmed-author:GrazianoFF,
pubmed-author:LabiancaRR,
pubmed-author:MarxPP,
pubmed-author:PanceraGG,
pubmed-author:PrioloDD
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
205-8
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:12562645-Adult,
pubmed-meshheading:12562645-Aged,
pubmed-meshheading:12562645-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12562645-Cisplatin,
pubmed-meshheading:12562645-Deoxycytidine,
pubmed-meshheading:12562645-Disease Progression,
pubmed-meshheading:12562645-Female,
pubmed-meshheading:12562645-Humans,
pubmed-meshheading:12562645-Infusions, Intravenous,
pubmed-meshheading:12562645-Male,
pubmed-meshheading:12562645-Middle Aged,
pubmed-meshheading:12562645-Neutropenia,
pubmed-meshheading:12562645-Palliative Care,
pubmed-meshheading:12562645-Pancreatic Neoplasms,
pubmed-meshheading:12562645-Survival,
pubmed-meshheading:12562645-Thrombocytopenia,
pubmed-meshheading:12562645-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
|
|
pubmed:affiliation |
Department and Unit of Medical Oncology, Parma, Italy. Cascinu@ yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
